Global Contrast Agents Market Insights: Impact of COVID-19 and Future Expectations to 2025
The Contrast Agents market revenue was 5130 Million USD in 2019, and will reach 6705 Million USD in 2025, with a CAGR of 4.56% during 2020-2025. Contrast agents are chemicals used in diagnostic imaging procedures such as CT scans, MRIs, X-rays, ultrasounds, and related procedures. They enhance the internal structure of the body and provide high-quality images, which help in providing an accurate diagnosis. It is widely used in radiology, interventional radiology, and interventional cardiology.
This report elaborates the market size, market characteristics, and market growth of the Contrast Agents industry, and breaks down according to the type, application, and consumption area of Contrast Agents. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Contrast Agents in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Contrast Agents market covered in Chapter 11:
Spago Nanomedical
Aposense
Shanghai Xudong Haipu Pharmaceutical
Jiangsu Hengrui Medicine
Bracco Diagnostic
Covidien
nanoPET Pharma GmbH
Guerbet Group
Yangtze River Pharmaceutical
Eli Lilly
Lantheus Medical Imaging
Guerbet Group
Bayer Healthcare
Alseres Pharmaceuticals
GE Healthcare
Subhra Pharma
In Chapter 3, on the basis of types, the Contrast Agents market from 2015 to 2025 is primarily split into:
Lodinated
Barium-based
Gadolinium-based
Microbubble
In Chapter 4, on the basis of applications, the Contrast Agents market from 2015 to 2025 covers:
Cardiovascular disorders
Neurological disorders
Gastrointestinal disorders
Cancer
Nephrological disorders
Musculoskeletal disorders
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
2019
This report elaborates the market size, market characteristics, and market growth of the Contrast Agents industry, and breaks down according to the type, application, and consumption area of Contrast Agents. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Contrast Agents in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Contrast Agents market covered in Chapter 11:
Spago Nanomedical
Aposense
Shanghai Xudong Haipu Pharmaceutical
Jiangsu Hengrui Medicine
Bracco Diagnostic
Covidien
nanoPET Pharma GmbH
Guerbet Group
Yangtze River Pharmaceutical
Eli Lilly
Lantheus Medical Imaging
Guerbet Group
Bayer Healthcare
Alseres Pharmaceuticals
GE Healthcare
Subhra Pharma
In Chapter 3, on the basis of types, the Contrast Agents market from 2015 to 2025 is primarily split into:
Lodinated
Barium-based
Gadolinium-based
Microbubble
In Chapter 4, on the basis of applications, the Contrast Agents market from 2015 to 2025 covers:
Cardiovascular disorders
Neurological disorders
Gastrointestinal disorders
Cancer
Nephrological disorders
Musculoskeletal disorders
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
